Cancer Related Urinary Peptides / Antigens

2019 John A. Catanzaro

The urinary peptide pool in cancer patients is rich in antigens that can be represented as neoantigens presented back to the immune system after processing working along with Langerhans cells (APC) for T cell presentation.

The HLA typing can identify the unique immunogenic peptides for the most potent immunogenic related to the expressed cancer.

Isolation of urinary peptides, tumor tissue peptides and serum related peptides was the standard on every patient I treated. The unique peptide typing using HLA genetics was consistent in identifying cancer related antigens for use in immune defense.

Image for post
Image for post

John A. Catanzaro is CEO of Neo7logix, a bioscience company that designs precision and personalized treatment designs.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store